Literature DB >> 7550977

Solid-phase extraction of nicotine and its metabolites for high-performance liquid chromatographic determination in urine.

P Zuccaro1, I Altieri, M Rosa, A R Passa, S Pichini, R Pacifici.   

Abstract

A solid-phase extraction, using Extrelut-1 glass columns, has been applied to urine samples of both passive and active smokers for high-performance liquid chromatographic determination of nicotine and its metabolites cotinine and trans-3'-hydroxycotinine. Chromatography was performed using a reversed-phase LC8DB column and a mobile phase consisting of water-acetonitrile (80:9, v/v) containing 5 ml triethylamine, 670 mg/l sodium heptanesulphonate, and 0.034 M each of K2HPO4 and citric acid (pH 4.4), at a flow-rate of 1.6 ml/min. The results obtained indicate that solid-phase extraction is a reliable and quick procedure which can be applied also to other nicotine metabolites.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7550977     DOI: 10.1016/0378-4347(95)00066-r

Source DB:  PubMed          Journal:  J Chromatogr B Biomed Appl        ISSN: 1572-6495


  3 in total

1.  Self-Reported Smoking Compared to Serum Cotinine in Bariatric Surgery Patients: Smoking Is Underreported Before the Operation.

Authors:  Paula J D Wolvers; Sjoerd C Bruin; Willem M Mairuhu; Monique de Leeuw-Terwijn; Barbara A Hutten; Dees P M Brandjes; Victor E A Gerdes
Journal:  Obes Surg       Date:  2020-01       Impact factor: 4.129

2.  Enzyme-linked immunosorbent assay of nicotine metabolites.

Authors:  Akiko Matsumoto; Toshihiro Ino; Mitsuhiro Ohta; Tetsuya Otani; Sachiko Hanada; Atsushi Sakuraoka; Akane Matsumoto; Masayoshi Ichiba; Megumi Hara
Journal:  Environ Health Prev Med       Date:  2010-01-08       Impact factor: 3.674

3.  Simultaneous and sensitive measurement of nicotine, cotinine, trans-3'-hydroxycotinine and norcotinine in human plasma by liquid chromatography-tandem mass spectrometry.

Authors:  Diaa M Shakleya; Marilyn A Huestis
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-08-28       Impact factor: 3.205

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.